Feb 29, 2024 / 01:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx fourth quarter and full-year 2023 earnings call. As a reminder, today's conference call is being recorded.
I would now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Ms. Notaro, you may begin.
Whitney Notaro - GoodRx Holdings - Vice President of Investor Relations
Thank you, operator. Good morning, everyone, and welcome to GoodRx's earnings conference call for the fourth quarter and full-year 2023. Joining me today are Scott Wagner, our Interim Chief Executive Officer; and Karsten Voermann, our Chief Financial Officer.
Before we begin, I'd like to remind everyone that this call will contain forward-looking statements. All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements including, without limitation, statements regarding management's plans, strategies, goals and objectives, our market opportunity, our anticipated financial performance,
Q4 2023 GoodRx Holdings Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot